New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on November 21, 2025.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lilly Endowment Inc, a significant shareholder of Eli Lilly & Co, has recently sold 37,148 shares of the company’s stock. This transaction amounts to a substantial $39,066,965.
Recent Updates on LLY stock
Eli Lilly & Co. has announced updates on several ongoing clinical studies that could impact its stock performance. The company is conducting a Phase 2 study on brenipatide for smoking cessation, which could expand its portfolio in a high-demand market. Additionally, two Phase 3 studies on baricitinib aim to preserve beta-cell function and delay type 1 diabetes onset, potentially enhancing Eli Lilly’s position in diabetes treatment. A Phase 4 study on the long-term safety of pirtobrutinib for chronic lymphocytic leukemia could differentiate Eli Lilly in oncology. Lastly, the FORAGER-2 trial evaluates the efficacy of Vepugratinib in combination with other therapies for advanced bladder cancer, which could bolster its oncology portfolio. These developments suggest potential positive shifts in investor sentiment and market dynamics, contingent on successful trial outcomes.
Spark’s Take on LLY Stock
According to Spark, TipRanks’ AI Analyst, LLY is a Outperform.
Eli Lilly & Co’s strong financial performance and positive earnings call sentiment are the most significant factors driving the score. The company’s robust revenue growth, market share gains, and strategic pipeline advancements are key strengths. However, high leverage, declining cash flow metrics, and a premium valuation present potential risks.
To see Spark’s full report on LLY stock, click here.
More about Eli Lilly & Co
YTD Price Performance: 36.15%
Average Trading Volume: 3,793,296
Technical Sentiment Signal: Buy
Current Market Cap: $992.3B